Faller, Douglas V.
Imunon Inc.,
United States
2025 Rank: 43598
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1708 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43598 | 46318 |
| Total Cites | 12340 | 13746 |
| H-index | 54 | 58 |
| Hm-index | 28 | 29 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 323 | 324 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 498 | 546 |
| Number of Single+First+Last Authored Papers | 153 | 153 |
| Total Cites to Single+First+Last Authored Papers | 8287 | 8938 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10630 | 11068 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
10.23%
|
|
Faller, Douglas V.
Oryzon Genomics,
United States
2024 Rank: 41255
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1700 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41255 | 44704 |
| Total Cites | 11826 | 13205 |
| H-index | 53 | 56 |
| Hm-index | 27 | 29 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 314 | 315 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 481 | 528 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 8076 | 8724 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10191 | 10608 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
10.44%
|
|
Faller, Douglas V.
Boston University Chobanian & Avedisian School of Medicine,
United States
2023 Rank: 39292
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1685 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39292 | 41891 |
| Total Cites | 11384 | 12694 |
| H-index | 51 | 55 |
| Hm-index | 27 | 28 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 306 | 307 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 472 | 517 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 7906 | 8542 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9814 | 10200 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
10.32%
|
|
Faller, Douglas V.
Takeda Oncology,
United States
2022 Rank: 36453
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1648 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36453 | 39588 |
| Total Cites | 10858 | 12090 |
| H-index | 51 | 54 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 296 | 297 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 456 | 500 |
| Number of Single+First+Last Authored Papers | 149 | 149 |
| Total Cites to Single+First+Last Authored Papers | 7673 | 8293 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9365 | 9716 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
10.19%
|
|
Faller, Douglas V.
Takeda Oncology,
United States
2021 Rank: 34800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1569 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34800 | 37853 |
| Total Cites | 10546 | 11763 |
| H-index | 50 | 53 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 292 | 293 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 449 | 493 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 7512 | 8136 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9113 | 9456 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
10.35%
|
|
Faller, Douglas V.
Boston University School of Medicine,
United States
2020 Rank: 32577
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1273 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32577 | 34369 |
| Total Cites | 10021 | 11197 |
| H-index | 48 | 52 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 286 | 287 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 438 | 482 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 7281 | 7884 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8642 | 8972 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.25 |
| Self-Citation Percentage |
10.50%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.